• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自P3HR-1、RAJI和Hk-Ly-28细胞系的可溶性补体结合抗原之间的差异。

Differences between soluble complement-fixing antigens derived from P3HR-1, RAJI, and Hk-Ly-28 cell lines.

作者信息

Weliky N, Leaman D H, Kallman B J

出版信息

J Natl Cancer Inst. 1975 Mar;54(3):593-6.

PMID:164559
Abstract

Soluble complement-fixing (CF) antigens of the virus-producing and virus-nonproducing P3HR-1 and RAJI Burkitt lymphoma cell lines and Hk-Ly-28 nasopharyngeal cancer cell line, identified by use of viral capsid antigen-positive human sera, could readily be distinguished by differences in their stability to chemical and physical conditions. The P3HR-1 soluble CF antigen lost titer when heated or exposed to acid perchlorate under conditions in which RAJI and Hk-Ly-28 soluble antigens were stable. Differences in solubility were also found. These results contribute not only to the interpretation of the relationship of Epstein-Barr virus (EBV)-associated components of RAJI to P3HR-1 and Hk-Ly-28 cell lysates but also to the selection of conditions for the development of identification tests and purification procedures for CF antigens and antibodies of Burkitt's lymphoma, nasopharyngeal cancer, and other EBV-associated tumors.

摘要

通过使用病毒衣壳抗原阳性的人血清鉴定出,产生病毒和不产生病毒的P3HR - 1和RAJI伯基特淋巴瘤细胞系以及Hk - Ly - 28鼻咽癌细胞系的可溶性补体结合(CF)抗原,可根据它们对化学和物理条件稳定性的差异轻易区分。在RAJI和Hk - Ly - 28可溶性抗原稳定的条件下,P3HR - 1可溶性CF抗原在加热或暴露于高氯酸时滴度会降低。还发现了溶解度的差异。这些结果不仅有助于解释RAJI中与爱泼斯坦 - 巴尔病毒(EBV)相关成分与P3HR - 1和Hk - Ly - 28细胞裂解物之间的关系,也有助于为伯基特淋巴瘤、鼻咽癌和其他EBV相关肿瘤的CF抗原及抗体的鉴定试验和纯化程序的开发选择条件。

相似文献

1
Differences between soluble complement-fixing antigens derived from P3HR-1, RAJI, and Hk-Ly-28 cell lines.源自P3HR-1、RAJI和Hk-Ly-28细胞系的可溶性补体结合抗原之间的差异。
J Natl Cancer Inst. 1975 Mar;54(3):593-6.
2
Stability and dissociation of P3H4-1 Burkitt's lymphoma cell soluble complement-fixing antigen identified with human serum.用人类血清鉴定的P3H4-1伯基特淋巴瘤细胞可溶性补体结合抗原的稳定性和解离
Cancer Res. 1975 Jun;35(6):1580-5.
3
Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies.从两种伯基特淋巴瘤细胞系中纯化可溶性补体结合抗原。影响抗原和抗体稳定性及回收率的条件。
Immunology. 1975 Oct;29(4):779-90.
4
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).一种源自髓系白血病的人类细胞系(K562)与一种人类伯基特淋巴瘤细胞系(P3HR - 1)的杂交。
J Natl Cancer Inst. 1980 Apr;64(4):725-38.
5
Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.爱泼斯坦-巴尔病毒的中和作用与该病毒诱导产生的细胞膜抗原抗体之间的关系。
J Natl Cancer Inst. 1970 Nov;45(5):989-95.
6
Functional association of class II antigens with cell surface binding of Epstein-Barr virus.II类抗原与爱泼斯坦-巴尔病毒细胞表面结合的功能关联。
J Immunol. 1985 Jun;134(6):3776-80.
7
Complement receptor expression by neoplastic and normal human cells.肿瘤细胞和正常人类细胞的补体受体表达
J Immunol. 1983 Aug;131(2):899-905.
8
Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
Cancer Res. 1977 Jul;37(7 Pt 1):2291-6.
9
Prevalence of antibodies to soluble antigen of Epstein-Barr virus-producing cells (P3HR-1) in the sera of hamadryas baboons of the high lymphoma incidence stock.
Exp Pathol (Jena). 1979;17(9):517-20. doi: 10.1016/s0014-4908(79)80072-1.
10
Studies on the B lymphoblast antigen No. 1 (BB-1) on a series of Burkitt lymphoma lines differing in the expression of the EBV/C3 receptor complex.对一系列在EBV/C3受体复合物表达上存在差异的伯基特淋巴瘤细胞系中的B淋巴母细胞抗原1(BB-1)的研究。
J Immunol. 1983 May;130(5):2448-52.

引用本文的文献

1
Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies.从两种伯基特淋巴瘤细胞系中纯化可溶性补体结合抗原。影响抗原和抗体稳定性及回收率的条件。
Immunology. 1975 Oct;29(4):779-90.